CN111773346A - Broad-spectrum plant composition for efficiently curing stomach cancer and preparation method thereof - Google Patents
Broad-spectrum plant composition for efficiently curing stomach cancer and preparation method thereof Download PDFInfo
- Publication number
- CN111773346A CN111773346A CN202010707298.5A CN202010707298A CN111773346A CN 111773346 A CN111773346 A CN 111773346A CN 202010707298 A CN202010707298 A CN 202010707298A CN 111773346 A CN111773346 A CN 111773346A
- Authority
- CN
- China
- Prior art keywords
- parts
- portions
- alkaloid
- gastric cancer
- broad
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a broad-spectrum plant composition for efficiently curing stomach cancer and a preparation method thereof, belonging to the field of medical application, wherein the composition is prepared from the following raw materials: water, tripterygium wilfordii alkaloid, triptolide, gelsemium elegans, chamaejasmine, pinellia tuber extract, amomum cardamomum fruit extract and penicillin sodium. It has the functions of preventing and treating, high preventing and treating effect and high cure rate. The pain and the injury of toxic and side reactions of weakness, alopecia, neurotoxicity, local tissue necrosis and the like of the gastric cancer patient caused by negative side effects while the gastric cancer cells are killed and killed by the factor treatment such as operation, radiotherapy, chemotherapy, targeted therapy, immunotherapy and the like are avoided for the gastric cancer patient.
Description
Technical Field
The invention relates to the field of medical application, in particular to a broad-spectrum plant composition for efficiently curing gastric cancer and a preparation method thereof.
Background
The gastric cancer belongs to the disease categories of gastric cavity disease, regurgitation, hiccup, accumulation and the like in the traditional Chinese medicine, the gastric cancer refers to malignant tumor which is originally developed on gastric mucosa epithelium and is one of the most common malignant tumors, and the gastric cancer is found in all people, and the incidence rate of the gastric cancer is the first of digestive tract cancer in the middle-aged and young people.
The traditional Chinese medicine considers that the disease is mainly accumulated due to weakness of spleen and stomach, together with anxiety and anxiety to hurt spleen, anger to hurt liver, and qi stagnation for a long time. Or excessive drinking, addiction to spicy food, stomach heat accumulation, depletion of body fluid and blood dryness, and accumulation of heat. Or for improper diet, hunger or cold food, smoked, pickled, fried, baked and mildewed food is often eaten. Or overeating and damaging the spleen and stomach. Phlegm-qi, blood stasis and heat are combined due to deficiency of qi and blood and emotional and dietary factors, resulting in gastric cancer.
At present, no complete cure and radical treatment prescription for stomach cancer disease taiyin exists all over the world, the main method for the comprehensive treatment of stomach cancer in China can only be completed through surgical operation, radiotherapy and chemotherapy, targeted therapy and immunotherapy, wherein about 80% of stomach cancer patients need to suffer from gastric resection, however, for the stomach cancer patients who are applied to resection, if professional nursing is not available, once factor complications such as site infection and the like occur, disastrous consequences can be caused by improper treatment, and even the life is threatened. Therefore, even though the recovery of the gastric cancer patient is accelerated after the gastrectomy, the recovery has influence on the life quality of the gastric cancer patient, and the postoperative chemoradiotherapy still avoids the pain and the injury of toxic and side reactions of the gastric cancer patient, such as weakness, alopecia, neurotoxicity, facial tissue necrosis and the like caused by negative sidedness while the lethal cancer cells brought by the operative chemoradiotherapy cannot be used, so that the gastric cancer patient still needs to face the reality of uncertain factors such as malignant lesion, diffusion transfer and the like unsuspectingly, and thus the doctor and the elder can appear at any time.
Disclosure of Invention
The invention aims to provide a broad-spectrum plant composition for efficiently curing gastric cancer and a preparation method thereof, and aims to solve the technical problems that if professional nursing is not available after surgery, chemoradiotherapy, targeted therapy and immunotherapy are used for curing gastric cancer, once factor complications such as site infection and the like occur, disastrous results are caused by improper treatment, and even life is threatened.
In order to solve the technical problems, the invention provides a broad-spectrum plant composition for efficiently curing gastric cancer, which is prepared from the following raw materials: water, tripterygium wilfordii alkaloid, triptolide, gelsemium elegans, chamaejasmine, pinellia tuber extract, amomum cardamomum fruit extract and penicillin sodium.
Preferably, the composition is prepared from the following raw materials: 988 parts of water, 3800-6800 parts of tripterygium alkaloid, 3800-6800 parts of triptolide, 3800-5800 parts of gelsemium, 3800-6800 parts of chamaejasmine, 3800-4500 parts of pinellia tuber extract, 8000-8800 parts of amomum cardamomum fruit extract and 0.01-0.08 parts of penicillin sodium.
Preferably, the composition is prepared from the following raw materials:
988 parts of water, 5000 parts of tripterygium wilfordii alkaloid 4000-.
Preferably, the composition is prepared from the following raw materials:
988 parts of water, 4500 parts of tripterygium alkaloid, 4300 parts of triptolide, 4300 parts of gelsemium, 4200 parts of chamaejasmine, 4000 parts of tuber extract of pinellia, 8500 parts of amomum cardamomum fruit extract and 0.05 part of penicillin sodium.
Preferably, the composition further comprises: 8000 portions of cubebin-, 8000-9000 parts of glycyrrhetinic acid, 9000 parts of mineral 8000-9000 parts of cistanche deserticola, 9000 parts of smilax glabra saponin alkaloid, 9000 parts of achyranthes bidentata sterol 8000-9000 parts, 8000-9000 parts of oriental wormwood flavone 8000-8000 parts, 8000-9000 parts of danshenxintong, 6000-8000 parts of sanzanol, 8800-9800 parts of astragaloside 8800-8800 parts, 8800-9800 parts of yam germanium-8800-9800 parts of cassia tora 88000 parts, 8500-88000 parts of dried orange peel flavone-9800 parts, 8000-9000 parts of phytolaccaine 8808800 parts, 8800-9800 parts of lycine-8800-9800 parts of lyratine, 8000-9000 parts of lygodium chloranthraceum chlorogenic acid, 10000-15000 parts of red date cyclic adenosine monophosphate, 0-9800 parts of polygonum multiflorum, 0-8800 parts, hawthorn flavone-9800 parts of dried root extract, 0-9800 parts of folic acid, 0.4-0.8 parts of zinc sulfate.
Preferably, the composition further comprises: 8800 portion of elecampane volatile oil 9800 portion, 8800 portion of costus lactone 9800 portion, 8800 portion of katsumadai volatile oil 9800 portion, 8000 portion of long pepper volatile oil 8800 portion, 8800 portion of atractylodes macrocephala volatile oil 9800 portion, 8800 portion of tsaoko volatile oil 9800 portion, 8000 portion of eupatorium volatile oil 9000 portion, 8800 portion of coix lachryma-jobi ester 9800 portion, 8000 portion of angelica volatile oil 9000 portion and 8000 portion of psoralea corylifolia volatile oil 9000 portion.
Preferably, the tripterygium alkaloid comprises five alkaloids, namely tripterygium alkaloid, tripterygium increasertibetan, tripterygium wilfordii jin alkali, tripterygium wilfordii alkali.
In addition, the invention also provides a preparation method of the broad-spectrum plant composition for efficiently curing the gastric cancer, which comprises the following steps:
step one, adding tripterygium alkaloid, triptolide, gelsemium, chamaejasmine and tuber of pinellia tuber extract into water and uniformly mixing;
step two, adding penicillin sodium into the solution obtained in the step one, and mixing uniformly again;
step three, heating the solution obtained in the step two to 70-80 ℃, adding the amomum cardamomum fruit extract into the solution obtained in the step two, continuously heating to 70-80 ℃, homogenizing under the homogenizing pressure of 5-15MPa, cooling to room temperature, and sealing for storage.
Preferably, the preparation method of the tripterygium alkaloid and the triptolide comprises the following steps: screening qualified herba Polygoni Perfoliati, removing impurities, collecting root, stem and leaf, drying, adding 1.5 times of ethanol, and leaching for 2-3 times to obtain herba Polygoni Perfoliati alkaloid and triptolide.
Preferably, the preparation method of the amomum cardamomum fruit extract comprises the following steps: screening qualified fructus Amomi rotundus, removing impurities, drying, distilling-extracting, and separating by capillary gas chromatography to obtain tuber extract.
Compared with the prior art, the invention has the characteristics and beneficial effects that: the broad-spectrum plant composition for efficiently curing the gastric cancer provided by the invention has the double functions of prevention and treatment, and is good in prevention and treatment effect and high in cure rate. The pain and the injury of toxic and side reactions of weakness, alopecia, neurotoxicity, local tissue necrosis and the like of the gastric cancer patient caused by negative side effects while the gastric cancer cells are killed and killed by the factor treatment such as operation, radiotherapy, chemotherapy, targeted therapy, immunotherapy and the like are avoided for the gastric cancer patient.
Detailed Description
In order to make the technical means, innovative features, objectives and functions realized by the present invention easy to understand, the present invention is further described below.
The examples described herein are specific embodiments of the present invention, are intended to be illustrative and exemplary in nature, and are not to be construed as limiting the scope of the invention. In addition to the embodiments described herein, those skilled in the art will be able to employ other technical solutions which are obvious based on the disclosure of the claims and the specification of the present application, and these technical solutions include technical solutions which make any obvious replacement or modification for the embodiments described herein.
The preparation method of the broad-spectrum plant composition for efficiently curing the gastric cancer comprises the following steps:
step one, preparing raw materials according to table 1, adding tripterygium alkaloid, triptolide, gelsemine, chamaejasmine and tuber of pinellia ternate extract into water, and uniformly mixing;
step two, adding penicillin sodium into the solution obtained in the step one, and mixing uniformly again;
step three, heating the solution obtained in the step two to 70-80 ℃, adding the amomum cardamomum fruit extract into the solution obtained in the step two, continuously heating to 70-80 ℃, homogenizing under the homogenizing pressure of 5-15MPa, cooling to room temperature, and sealing for storage.
The preparation method of the tripterygium wilfordii alkaloid and triptolide comprises the following steps: screening qualified herba Polygoni Perfoliati, removing impurities, collecting root, stem and leaf, drying, adding 1.5 times of ethanol, and leaching for 2-3 times to obtain herba Polygoni Perfoliati alkaloid and triptolide.
The preparation method of the gelsemine comprises the following steps: screening qualified caulis Piperis Futokadsurae, removing impurities, drying, adding 1.5-2 times of water, steaming, and filtering until Baume degree is 15-17.
The preparation method of the chamaejasmine comprises the following steps: screening qualified chamaejasmine, removing impurities, collecting root, stem and leaf, drying, adding 1.5-2 times of water, steaming, and filtering until Baume degree is 15-17.
The preparation method of the pinellia tuber extract comprises the following steps: screening qualified pinellia ternate, removing impurities, taking tubers of the pinellia ternate, drying, adding water with the dosage of 1.5-2 times, cooking and filtering until the Baume degree is 15-17.
The preparation method of the amomum cardamomum fruit extract comprises the following steps: screening qualified fructus Amomi rotundus, removing impurities, drying, distilling-extracting, and separating by capillary gas chromatography to obtain tuber extract.
Optionally, in the step one, 8000 portions of cubebin-8800, 8000 portions of kaki flavone-, 9000 parts of lotus seed core alkaloid 8000-, 8500-9800 parts of tangerine peel flavone, 9000 parts of 8000-phytolaccagenin, 9000 parts of emodin 8000-980 parts of lycium barbarum betaine 8800-9800 parts, 9000 parts of 8000-9000 parts of lygodium chloranthum chlorogenic acid, 10000-15000 parts of red date cyclic adenosine monophosphate, 8800-9800 parts of garden balsam seed, 8800-9800 parts of hawthorn flavone 8800-9800 parts, 8800 parts of polygonum multiflorum dried root extract, 0.4-0.8 parts of folic acid and 10-16 parts of zinc sulfate.
In addition, the elecampane volatile oil 8800-9800, the costus lactone 8800-9800, the alpinia katsumadai volatile oil 8800-9800, the long pepper volatile oil 8000-8800, the atractylodes macrocephala volatile oil 8800-9800, the amomum tsao-ko volatile oil 8800-9800, the eupatorium volatile oil 8000-9000, the coicis ester 8800-9800, the angelica volatile oil 8000-9000 and the fructus psoraleae volatile oil 8000-9000 can also be added.
The Tripterygium wilfordii alkaloid is extract of dried root, stem, and leaf of Tripterygium wilfordii hook F.H.Cheng of Celastraceae, and comprises alkaloid, hypercalcine, jin alkali, chun alkali, and tosine. According to a large number of documents, the tripterygium wilfordii alkaloid has the characteristics of broad spectrum, high efficiency, various action modes and the like on cancer cells, and has the advantages of unique action mechanism, complex action part, good prevention and treatment effect in clinical application, high cure rate, and simultaneous treatment of the same diseases and the different diseases. The chemical component of the tripterygium wilfordii alkaloid, namely sesquiterpene alkaloid, is a main physiological active substance in tripterygium wilfordii, the action mechanism of the tripterygium wilfordii alkaloid on various types of cancer cells causes slow action, stopping taking food, then anaesthetizing, and then reviving or dying of toxic cancer cells of a test mouse and a human body, and the revived cancer cells can be taken food, anaesthetized, revived or killed again. Tripterygium wilfordii contains more than 20 kinds of alkaloid, and the alkali fixing, alkali increasing, alkali promoting, alkali relieving and alkali throwing adopted by the invention can better 'tic and kill' the activity of various types of cancer cells compared with other alkaloids.
The triptolide is dried root extract of radix Tripterygii Wilfordii of Celastraceae, and contains triptolide; triptolide is a diterpene lactone with multiple biological activities, is derived from root of medicinal plant Tripterygium wilfordii hook F, has effect of killing various cancer cells, and can be used in combination with Tripterygium wilfordii alkaloid to enhance the effect of killing various cancer cells.
Gelsemiine is extract of perennial green vine of caulis Piperis Futokadsurae of Loganiaceae, and contains highly toxic components of caulis Piperis Futokadsurae; is liquid or slurry or powder with Baume degree of 15-17 extracted by organic solvent or water boiling method; the highly toxic active component of the compound has the functions of dispelling wind, counteracting toxic substance, relieving swelling and pain, resisting gastric cancer, etc.
The stellera chamaejasme is extract of stellera chamaejasme plant, also contains diterpene and volatile oil components, is liquid or paste or powder with Baume degree of 15-17 extracted from root, stem or leaf or one or two of the three by organic solvent or boiling method, the stellera chamaejasme is new chamaejasme A, new chamaejasme B or chamaejasme dry powder extracted from stellera chamaejasme; the chamaejasmine contains diterpene and volatile oil components, and has broad-spectrum anticancer, antibacterial, and pesticidal effects.
The pinellia ternata triterpene alcohol is extracted from tuber of pinellia ternata (Thunb.) Breit of Araceae, and has effects of eliminating dampness and phlegm, lowering adverse qi and relieving vomit, relieving distension and fullness and resolving hard mass.
The fructus Amomi rotundus extract is prepared from 5 kinds of alpha-pinene, caryophyllene, alpha-terpineol, limonene, and myrcene, is dried mature fruit extract of Amomum cardamomum or Amomum javanicum of Zingiberaceae, and has effects of activating qi-flowing, warming middle warmer, eliminating dampness, relieving oppression, promoting appetite, resolving food stagnation, enhancing gastrointestinal peristalsis, and promoting gastric secretion.
TABLE 1 raw material composition and amount for each example
The plant composition prepared by the invention is a liquid agent and can be directly used as a beverage. The daily dose of the medicine is 400-600 ml to 6-8 months. It is contraindicated for pregnant women, and can be drunk after termination of gestation period.
In the invention, 6 patients with specific diagnosis of gastric cancer are selected.
One of the patients cured by gastric cancer: mr. Zhao, 35 years old, Ningbo in Zhejiang. Mr. Zhao often feels symptoms such as epigastric distension, discomfort, dull pain, anorexia and the like, the last gastric cancer patient is diagnosed in one third hospital in Shanghai in 6 months in 2000, partial gastric resection operation is carried out under the suggestion of doctors, the broad-spectrum plant composition liquid substance is directly drunk without chemoradiotherapy, after 8 months, the pathological condition of the gastric cancer is completely disappeared through comprehensive physical examination in hospitals, other indexes of the body are normal, and the gastric cancer does not relapse in 2 months in 2014.
The second patient with gastric cancer: the Tang lady, age 40, Tianjin people and Tang lady often feel stuffy and uncomfortable epigastric fullness, insomnia and dreamful sleep, dull pain in abdomen and no appetite, the later-stage gastric cancer patient is confirmed to be diagnosed by Tianjin Hospital in 3 months in 2001, the treating physician recommends that the Tang lady is treated by the operation of radiotherapy and chemotherapy, the Tang lady does not agree, the later three days after returning home is introduced by friends, and the stomach cancer disease of the Tang lady is not relapsed after the comprehensive physical examination of Tianjin Hospital after directly selecting and applying the liquid substance of the spectral plant composition of the invention for 6 months.
The third patient cured the gastric cancer: mr. li, 50 years old, guangdong, diagnosed as late gastric cancer in 6 months of 2002, without surgery, chemoradiotherapy and targeted therapy, after directly selecting to drink the liquid plant composition liquid for 6 months in the last 6 months of the same year, mr. li thoroughly disappears through comprehensive physical examination by a certain three hospitals in guangdong, and other indexes of the body are normal until mr. li gastric cancer does not recur in 2 months of 2014.
The fourth is the cure of gastric cancer: according to the method, a Pan woman, a 55-year-old Wenzhou person, a Beijing officer, a patient diagnosed in the middle stage of gastric cancer in 7 months in 2003 is diagnosed as a patient with gastric cancer, operation chemoradiotherapy is not carried out, after the patient is directly drunk with the liquid substance of the plant composition disclosed by friends in the middle ten days of the same year, the gastric cancer of the Pan woman is completely disappeared in the result through comprehensive physical examination in a Beijing Hospital hospital, other indexes of the body are normal, and the gastric cancer of the Pan woman does not relapse in 2 months in 2014.
The fifth of gastric cancer patients: the high-birth patient is 60 years old, Fujian people are diagnosed as middle and late gastric cancer patients in 2004 in 8 months, the patients are not subjected to operation, radiotherapy and chemotherapy, and after the patients are directly selected to drink the plant composition liquid substance introduced by friends for 7 months in the last ten days of the same year in 8 months, the high-birth gastric cancer diseases are completely disappeared by comprehensive physical examination in Beijing Hospital hospital, other indexes of the body are normal, and the high-birth gastric cancer diseases do not relapse until 2 months in 2014.
Six patients with gastric cancer: wu women, 66 years old, Shanghai, officials, patients diagnosed as middle and late gastric cancer in 6 months in 2005, without performing operative chemoradiotherapy, after directly selecting to drink the liquid substance of the plant composition of the invention by introduction of friends for 7 months in 6 middle ten days in the same year, the Wu women gastric cancer disease completely disappears after comprehensive physical examination in Beijing Hospital hospital, and other indexes of the body are normal, and the Wu women gastric cancer disease does not relapse and transfer until 2 months in 2014.
The above examples are only for describing the preferred embodiments of the present invention, and are not intended to limit the scope of the present invention, and various modifications and improvements made to the technical solution of the present invention by those skilled in the art without departing from the spirit of the present invention should fall within the protection scope defined by the claims of the present invention.
Claims (10)
1. The broad-spectrum plant composition for efficiently curing the gastric cancer is characterized by being prepared from the following raw materials: water, tripterygium wilfordii alkaloid, triptolide, gelsemium elegans, chamaejasmine, pinellia tuber extract, amomum cardamomum fruit extract and penicillin sodium.
2. The broad-spectrum plant composition for effectively curing gastric cancer according to claim 1, which is prepared from the following raw materials: 988 parts of water, 3800-6800 parts of tripterygium alkaloid, 3800-6800 parts of triptolide, 3800-5800 parts of gelsemium, 3800-6800 parts of chamaejasmine, 3800-4500 parts of pinellia tuber extract, 8000-8800 parts of amomum cardamomum fruit extract and 0.01-0.08 parts of penicillin sodium.
3. The broad-spectrum plant composition for effectively curing gastric cancer according to claim 1, which is prepared from the following raw materials:
988 parts of water, 5000 parts of tripterygium wilfordii alkaloid 4000-.
4. The broad-spectrum plant composition for effectively curing gastric cancer according to claim 1, which is prepared from the following raw materials:
988 parts of water, 4500 parts of tripterygium alkaloid, 4300 parts of triptolide, 4300 parts of gelsemium, 4200 parts of chamaejasmine, 4000 parts of tuber extract of pinellia, 8500 parts of amomum cardamomum fruit extract and 0.05 part of penicillin sodium.
5. The broad-spectrum plant composition for curing gastric cancer with high efficiency according to any one of claims 1 to 4, further comprising: 8000 portions of cubebin, 9000 portions of 8000 portions of kaki calyx flavone, 8800 portions of dendrobine 8000 portions of mangnolia officinalis, 8000 portions of immature bitter orange flavone 8800 portions, 8800 portions of areca peel alkaloid, 9800 portions of 8800 portions of selfheal triterpenoid saponin, 8800 portions of sculellaria barbata alkaloid, 9800 portions of selaginella hupensis alkaloid, 8800 portions of suberect spatholobus stem 8000 portions of mangnolia officinalis, 8800 portions of prepared rehmannia glutinosa, 8000 portions of dwarf lilyturf tuber amino acid, 8800 portions of heartleaf houttuynin, 8800 portions of honeysuckle chlorogenic acid, 9800 portions of linalool 8000 portions of Thunberg, 8000 portions of fritillary alkali, 9800 portions of carthamin, 9800 portions of cynanchum atratum, 8800 portions of baryotis sylvestris, 8000 portions of corymbose, 9000 portions of corymbose, 8000 portions of tuckahoe xylan, 8800 portions of santalone, 8800 portions of santalose, 8800 portions of corymbose, 8000-9000 parts of cistanche mineral substances, 9000 parts of smilax glabra saponin alkaloid 8000-9000 parts of achyranthes bidentata sterol 8000-9000 parts, 9000 parts of oriental wormwood flavone 8000-9000 parts, 9000 parts of danshenxintong 8000-8000 parts, 8000 parts of zanthoxylum 6000-8000 parts, 8800-9800 parts of astragaloside 8800-9800 parts, 8800-9800 parts of Chinese yam germanium-8800-8809800 parts of cassia seed essence 8800-88000 parts, 8500-9800 parts of tangerine peel flavone-88000 parts, 8000-9000 parts of phytolaccaine-8800-8809800 parts of lycium betaine-88000 parts, 8000-9000 parts of lygodium chlorogenate, 10000-15000 parts of red date cyclic adenosine monophosphate, 9800 parts of garden balsam seed essence 0-9800 parts, 0-9800 parts of hawthorn flavone-0-88000 parts, 0-9800 parts of polygonum multiflorum dried root extract, 9800 parts of folic acid and 10-16 parts of zinc sulfate.
6. The broad-spectrum plant composition for effectively curing gastric cancer according to claim 5, further comprising: 8800 portion of elecampane volatile oil 9800 portion, 8800 portion of costus lactone 9800 portion, 8800 portion of katsumadai volatile oil 9800 portion, 8000 portion of long pepper volatile oil 8800 portion, 8800 portion of atractylodes macrocephala volatile oil 9800 portion, 8800 portion of tsaoko volatile oil 9800 portion, 8000 portion of eupatorium volatile oil 9000 portion, 8800 portion of coix lachryma-jobi ester 9800 portion, 8000 portion of angelica volatile oil 9000 portion and 8000 portion of psoralea corylifolia volatile oil 9000 portion.
7. The broad-spectrum plant composition for effectively curing gastric cancer according to claim 6, wherein: the Tripterygium wilfordii alkaloid includes Tripterygium wilfordii alkaloid, Tripterygium wilfordii, Tripterygium wilfordii alkaloid, Tripterygium wilfordii alkaloid, and Tripterygium wilfordii alkali.
8. The method for preparing the broad-spectrum plant composition for curing gastric cancer with high efficiency according to any one of claims 1 to 7, characterized by comprising the following steps:
step one, adding tripterygium alkaloid, triptolide, gelsemium, chamaejasmine and tuber of pinellia tuber extract into water and uniformly mixing;
step two, adding penicillin sodium into the solution obtained in the step one, and mixing uniformly again;
step three, heating the solution obtained in the step two to 70-80 ℃, adding the amomum cardamomum fruit extract into the solution obtained in the step two, continuously heating to 70-80 ℃, homogenizing under the homogenizing pressure of 5-15MPa, cooling to room temperature, and sealing for storage.
9. The preparation method of the broad-spectrum plant composition for efficiently curing the gastric cancer according to claim 8, wherein the preparation method of the tripterygium alkaloid and the triptolide comprises the following steps: screening qualified herba Polygoni Perfoliati, removing impurities, collecting root, stem and leaf, drying, adding 1.5 times of ethanol, and leaching for 2-3 times to obtain herba Polygoni Perfoliati alkaloid and triptolide.
10. The method for preparing the broad-spectrum plant composition for effectively curing the gastric cancer according to claim 8, wherein the amomum cardamomum fruit extract is prepared by the following steps: screening qualified fructus Amomi rotundus, removing impurities, drying, distilling-extracting, and separating by capillary gas chromatography to obtain tuber extract.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010707298.5A CN111773346A (en) | 2020-07-21 | 2020-07-21 | Broad-spectrum plant composition for efficiently curing stomach cancer and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010707298.5A CN111773346A (en) | 2020-07-21 | 2020-07-21 | Broad-spectrum plant composition for efficiently curing stomach cancer and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111773346A true CN111773346A (en) | 2020-10-16 |
Family
ID=72764714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010707298.5A Pending CN111773346A (en) | 2020-07-21 | 2020-07-21 | Broad-spectrum plant composition for efficiently curing stomach cancer and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111773346A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115364076A (en) * | 2022-07-11 | 2022-11-22 | 中国人民解放军总医院第五医学中心 | Application of diterpenoid compound DB-022133 in preparation of medicine for treating gastric cancer |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101032478A (en) * | 2007-04-20 | 2007-09-12 | 福建医科大学附属协和医院 | Application of triptolide in the preparing of anti-alimentary tract tumor medicine |
| CN106310120A (en) * | 2016-08-31 | 2017-01-11 | 陈爱红 | Wide-spectrum traditional Chinese medicine composition water agent and preparation method thereof |
-
2020
- 2020-07-21 CN CN202010707298.5A patent/CN111773346A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101032478A (en) * | 2007-04-20 | 2007-09-12 | 福建医科大学附属协和医院 | Application of triptolide in the preparing of anti-alimentary tract tumor medicine |
| CN106310120A (en) * | 2016-08-31 | 2017-01-11 | 陈爱红 | Wide-spectrum traditional Chinese medicine composition water agent and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 陈伟芳等: "中药抗胃癌机制的实验研究进展 ", 《浙江中医杂志》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115364076A (en) * | 2022-07-11 | 2022-11-22 | 中国人民解放军总医院第五医学中心 | Application of diterpenoid compound DB-022133 in preparation of medicine for treating gastric cancer |
| CN115364076B (en) * | 2022-07-11 | 2024-04-16 | 中国人民解放军总医院第五医学中心 | Application of diterpenoid compound DB-022133 in preparation of medicines for treating gastric cancer |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103041317B (en) | A kind of Chinese medicine composition for the treatment of tumor and preparation method thereof | |
| CN102872261B (en) | The application of Physalis pubescens L. in the medicine of preparation treatment acute cholecystitis | |
| CN109010468A (en) | Antitumor Chinese and its preparation method and application based on ancient prescription Tuoli Xiaodu | |
| CN111773346A (en) | Broad-spectrum plant composition for efficiently curing stomach cancer and preparation method thereof | |
| CN104984296A (en) | Pharmaceutical composition for treating female climacteric syndrome and preparation method thereof | |
| CN104873828A (en) | Chinese herba preparation for treating radioactive skin injury and preparation method thereof | |
| CN104189764A (en) | Traditional Chinese medicinal preparation for treating intervention postoperative fever | |
| CN114632130A (en) | Traditional Chinese medicine composition for treating metaplasia atrophic gastritis | |
| CN113797294A (en) | Medicine composition for treating atrophic gastritis and preparation method thereof | |
| CN105233078A (en) | Traditional Chinese medicine composition for treating viral hepatitis | |
| CN104491816A (en) | Application of traditional Chinese medicinal composition in preparation of medicine for treating chronic gastroenteritis | |
| CN109512867A (en) | The Chinese medicine composition for treating abdominal pain | |
| CN108403824A (en) | A kind of combined traditional Chinese medicine cream for treating hemorrhoid | |
| CN115531488B (en) | Composition for soothing liver and strengthening spleen and being used for postoperative adjuvant therapy of breast cancer and preparation method thereof | |
| CN113144161B (en) | Externally applied traditional Chinese medicine composition for treating pelvic inflammation and pelvic effusion | |
| CN105521223A (en) | Traditional Chinese medicinal preparation for realizing adjuvant therapy on pancreatic cancer and preparation method of traditional Chinese medicinal preparation | |
| CN101693096A (en) | Medicament for treating liver cancer and preparation method thereof | |
| CN105727069A (en) | Medicinal composition for treating chronic cholecystitis and preparation method for medicinal composition | |
| CN105311331A (en) | Traditional Chinese medicine composition for treating eczema and preparation method thereof | |
| CN104940826A (en) | Medicine for treating stomach disease | |
| CN104645247A (en) | Traditional Chinese medicine preparation for treating hepatolenticular degeneration and preparation method of traditional Chinese medicine preparation | |
| CN104888091A (en) | Traditional Chinese medicine composition for treating intestinal form of acute radiation sickness and preparation method of traditional Chinese medicine composition | |
| CN104606427A (en) | Schefflera arboricola-contained traditional Chinese medicinal composition | |
| CN104587122A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| CN104606426A (en) | Traditional Chinese medicinal composition preparation for treating chronic gastritis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201016 |